Mental health conditions can take a staggering toll on an individual physically, socially, and financially. Many patients languish without effective treatment even though new options are constantly entering the market. There has to be a better, more precise way to identify patients with and at risk for treatment-resistant depression to break this cycle, broaden access to advanced therapies, and improve outcomes. At OM1, we believe there is a better way.
Join our webinar to learn how AI technology applied to Real-World Data can accelerate R&D and change the mental health patient journey. Drs. Carl Marci and Joseph Zabinski will explore:
- Defining Treatment-Resistant Depression beyond two antidepressant trials
- Defining a ‘Gold standard’ for capturing treatment resistance based on psychiatrists’ assessments
- Using AI to identify and find patients with TRD
- Validating AI-based approaches using clinical outcomes
- Other AI use cases for additional conditions in mental health